Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

AbbVie Plans North Chicago, Illinois, Ingredient Manufacturing Operations

02/27/2026
Global biopharmaceutical company AbbVie plans to establish production operations in North Chicago, Illinois. The $380 million project is expected to create 300 jobs.

The investment will include the construction of two new active pharmaceutical ingredient manufacturing facilities to support the production of next-generation neuroscience and obesity-reduction medicines. Production is scheduled to begin in 2029.

“This milestone demonstrates further progress against AbbVie’s $100 billion commitment to U.S. R&D and capital investments over the next decade,” said Robert A. Michael, chairman and chief executive officer, AbbVie. “By strengthening AbbVie’s U.S. manufacturing capabilities, we are well-positioned to support our investment in innovation and enhance our ability to deliver next-generation medicines to patients.”

To support the project the company will receive a tax credit worth an estimated $25 million over 15 years through the state’s Economic Development for a Growing Economy agreement.

“By leveraging our economic development tools, the State of Illinois is supporting AbbVie in their efforts to expand advanced manufacturing, create hundreds of quality jobs, and keep Illinois at the forefront of innovation in next-generation medicines,” noted Illinois Department of Commerce and Economic Opportunity (DCEO) Director Kristin Richards.

"AbbVie’s expansion in Illinois reinforces our state’s standing as a global life sciences leader,” added Illinois Economic Development Corporation President and CEO Christy George. “From world-class research institutions and a highly skilled workforce to a deeply integrated manufacturing and logistics network, Illinois offers the full ecosystem required for biopharmaceutical innovation. We are proud that AbbVie continues to grow its legacy here, advancing breakthrough medicines and creating high-quality jobs that strengthen communities across our state.”

AbbVie discovers, develops, manufactures, and markets medicines and therapies to address health conditions such as immunology, oncology, neuroscience, virology, and beyond. The company’s portfolio includes blockbuster drugs like Humira, Skyrizi, and Rinvoq.

Exclusive Research